News As Trump visits UK, GSK pledges $30bn in US investment GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.
Sales & Marketing Tariffs, pharma, and patients: A Q&A with Orr Inbar In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.
News EU-US trade deal includes 15% pharma tariff Details have been published of the trade agreement between the US and EU, with confirmation of the tariff rates for pharmaceuticals.
News Trump orders stockpiling of essential medicine ingredients Trump has ordered the creation of a six-month stockpile of ingredients to make essential medicines, in another part of his push to reshore production.
News Under pressure from Trump, Lilly hikes Mounjaro prices in UK Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.
News Trump gives pharma ultimatum on most favoured nation pricing President Trump has given 17 pharma companies until 29th September to commit to providing lower prices "to every single Medicaid patient."
News Ambros' $125m for pain disorder drug, and other financings Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.